azomycin has been researched along with osimertinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, W; Jia, T; Miao, R; Shao, J; Zeng, L; Zhang, C; Zhang, J; Zhao, Y; Zhu, H | 1 |
1 other study(ies) available for azomycin and osimertinib
| Article | Year |
|---|---|
Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Humans; Hypoxia; Lung Neoplasms; Nitroimidazoles; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Structure-Activity Relationship | 2023 |